Australian Coalition Taskforce Calls for 80% Tobacco Tax Cut to Combat Illicit Market

Aug.27
Australian Coalition Taskforce Calls for 80% Tobacco Tax Cut to Combat Illicit Market
According to SGST on August 26, 2026, Australia’s Coalition Illegal Tobacco Taskforce released a report recommending an up to 80% cut in tobacco excise to reduce the appeal of the illicit tobacco market. The report claimed organised crime groups now control about 80% of Australia’s tobacco market and argued that high excise rates have widened the price gap between legal and illegal products. The recommendation remains a policy proposal and has not been adopted by the Australian government, which said its focus remains on enforcement, compliance and additional resources.

Key Points

  • Australia’s Coalition Illegal Tobacco Taskforce released a report recommending an up to 80% reduction in tobacco excise.
  • The report claims organised crime groups control about 80% of Australia’s tobacco market, a figure based on the taskforce’s assessment rather than official government statistics.
  • The Australian Criminal Intelligence Commission estimated illicit tobacco losses reached about A$4 billion in 2023-24.
  • Tobacco excise revenue declined from around A$16 billion in 2019-20 to about A$8 billion in 2024-25.
  • The Australian government rejected calls for a tobacco tax cut and said it would continue focusing on enforcement and compliance measures.

2Firsts

August 27, 2026

According to SGST on August 26, 2026, Australia’s Coalition Illegal Tobacco Taskforce released a report titled The Illicit Tobacco Crisis in Australia, recommending an up to 80% cut in tobacco excise to address the expansion of the illicit tobacco market. The report argued that lowering legal tobacco prices could narrow the gap between legal and illegal products and reduce incentives for organised crime groups.

The taskforce is co-chaired by Australian federal MP Mary Aldred and Liberal Senator Richard Colbeck. The report has renewed debate in Australia over the balance between tobacco taxation, illicit trade enforcement and public health objectives.

Report Highlights Role of Illegal Market in Tobacco Debate

The report claims that organised crime groups now control about 80% of Australia’s tobacco market and argues that continued tobacco excise increases have encouraged some consumers to turn to illegal channels.

It cited data showing nicotine consumption in Australia increased by nearly 40% between 2017 and 2025, while illicit sources have expanded their role in supplying consumers.

However, the 80% market-control figure reflects the taskforce’s assessment and is not an official Australian government market estimate.

The Australian Criminal Intelligence Commission (ACIC) estimated that illicit tobacco cost Australia about A$4 billion in 2023-24, a fourfold increase over three years. The agency has also linked criminal syndicates to more than 200 firebombings since 2023.

Enforcement Increases as Excise Revenue Declines

The Australian Border Force seized 2.53 billion cigarette sticks in 2024-25.

However, the report argued that enforcement alone has not been sufficient to address the illicit tobacco market.

Meanwhile, tobacco excise revenue has declined significantly.

Revenue fell from around A$16 billion in 2019-20 to about A$8 billion in 2024-25 and is expected to decline further to around A$2 billion by 2029-30.

The taskforce argued that the decline in revenue and growth of the illicit market show the need for a reassessment of current tobacco taxation policies.

Tax Cut Proposal Emerges as Alternative Approach

Mary Aldred said Australia needed to reconsider its tobacco excise policy, arguing that a 282% increase in excise rates since 2012 had contributed to consumers moving toward illegal markets.

She said Australia needed a broader strategy combining enforcement, regulation and market measures.

The report recommended:

● establishing a national framework for illicit tobacco control;

● creating a licensed framework for legal vape sales;

● introducing vape manufacturing standards and age restrictions;

● setting an “Effective Zero” smoking target of 5%.

Calls for tobacco tax reductions have recently emerged from multiple political groups.

New South Wales Premier Chris Minns previously said tobacco excise was too high and that enforcement alone was not solving the problem.

Australia’s One Nation party has also proposed a 75% tobacco excise cut and a three-year freeze on indexation.

Government Rejects Tobacco Tax Cut Proposal

The Australian government has rejected calls for a tobacco tax reduction.

Treasurer Jim Chalmers said the government was not considering an excise cut and emphasized that its focus remained on law enforcement, compliance and additional resources to combat illicit tobacco trade.

The debate highlights the policy challenge facing Australia as it seeks to balance public health objectives, tax revenue and illicit market control.

Follow 2Firsts for timely updates on global tobacco and nicotine regulations, market developments and industry trends.

Cover Image Source: SGST


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

FDA Authorizes JUUL2, Cites Adult Switching Amid Efforts to Speed PMTA Reviews
FDA Authorizes JUUL2, Cites Adult Switching Amid Efforts to Speed PMTA Reviews
The FDA authorized the JUUL2 device and tobacco- and menthol-flavored pods on Aug. 28, bringing the number of authorized e-cigarette products to 48. The agency highlighted complete switching among adult smokers, with six-week switching rates reaching 28.4%–49.3% for the menthol pod. The decision comes as FDA works to speed PMTA reviews, reduce application backlogs and expand authorized e-cigarette and nicotine-pouch products while maintaining enforcement priorities for unauthorized products.
Regulations
Aug.29
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
FDA’s Center for Tobacco Products detailed new PMTA review data and process changes at the 2026 FDLI conference. Pending PMTAs fell from about 450,000 at the start of 2025 to 135,000 by September 2026. CTP also discussed its 180-day review goal, current sPMTA pilot, alternate-supplier planning, more than 50,300 pending SE reports, and lessons from the nicotine pouch pilot already being applied to ENDS review.
Regulations
Oct.07
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia's Therapeutic Goods Administration published a final decision on September 25 to classify 6-methylnicotine as a Schedule 9 prohibited substance under the Poisons Standard, effective October 1, 2026. TGA said the chemical has been reported in e-cigarette liquids sold in Australia and marketed as nicotine-free or nicotine alternatives, while evidence also indicates its use in preparations such as oral pouches. The government originally proposed a Schedule 7 classification but ultimately adopted the stricter Schedule 9 designation, citing acute toxicity, dependence risk, use in unapproved consumer products and misleading marketing.
News
Sep.29 by 2Firsts Perspectives
Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Holdings said in its latest shareholder letter that it is moving to commercialize PACHA products and monetize its PMTA assets as the FDA changes enforcement priorities for unauthorized ENDS products. Thirty PACHA SKUs were previously tentatively identified for a proposed public list of products that the FDA generally does not intend to prioritize for enforcement. Charlie’s is also preparing test-market sales of age-gated flavored disposables and says it currently holds 678 PMTA-related product assets while seeking additional strategic transactions and partnerships.
Sep.11
Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
The U.S. Department of Health and Human Services has named Bret Koplow permanent director of the FDA’s Center for Tobacco Products, ending his period as acting chief. Koplow has spent years working on tobacco regulation, law and policy inside the FDA and, while serving as acting director, pushed for faster PMTA reviews and nicotine pouch review pilots. HHS also said CTP will prioritize innovation and access to less harmful alternatives for adult smokers while continuing efforts to protect youth.
Sep.09
U.S. Fifth Circuit Vacates NicQuid Vape MDO, Says FDA Comparative-Efficacy Standard Violated APA Procedures
U.S. Fifth Circuit Vacates NicQuid Vape MDO, Says FDA Comparative-Efficacy Standard Violated APA Procedures
According to VitalLaw on August 27, 2026, the U.S. Court of Appeals for the Fifth Circuit vacated an FDA marketing denial order (MDO) against NicQuid LLC, ruling that the agency’s comparative-efficacy standard for electronic nicotine delivery system (ENDS) applications had become a substantive rule requiring notice-and-comment rulemaking under the Administrative Procedure Act (APA). The court did not reject FDA’s authority to compare the public health benefits and risks of flavored vapes, but held that the agency could not establish a broadly binding standard through informal adjudications. The case was remanded to FDA for further proceedings.
Aug.28